Axsome Therapeutics (AXSM) Reports Q4 Loss Per Share of $0.12

Axsome Therapeutics (NASDAQ: AXSM) reported Q4 EPS of ($0.12), versus ($0.14) reported last year.

For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• NVE Corporation names new CEO and expands board to seven members
• MP Materials seen largely insulated after China export-control move